Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

With the nation’s healthcare system groaning under epic pressure, you would think that the pharmaceutical giants would be a little more judicious in the way they promote their drugs and sell them to federal, state, and municipal government programs. Perhaps they will be, now that the United States Department of Justice has slapped Pfizer with a record $2.3 billion fine for defrauding the Medicare and Medicaid programs.

Read the rest of this entry »

Springfield, Massachusetts, Baystate Medical Center is accusing one of its prominent anesthesiologists of providing fictitious data about the after-surgery benefits from painkillers like Vioxx and Celebrex.

Read the rest of this entry »

The Wall Street Journal reported in its Health Blog on May 21 that the Federal Aviation Administration has banned the stop-smoking drug Chantix for pilots and air traffic controllers.

According to the report, Pfizer’s smoking-cessation drug Chantix came in for a bit more trouble as a research group cited reports of physical side effects associated with the drug. The FAA, which reviewed the report, barred pilots and air traffic controllers from taking the drug, the WSJ reports.

Read the rest of this entry »